glp 1 muscle loss GLP-1 and Loss: Semaglutide, Tirzepatide & Lean Mass The Muscle Loss Conversation No

Patient Patient-Centered Outcomes Res 15(3):367377

Key takeaways Semaglutide is a GLP-1 receptor agonist that helps lower blood sugar levels for people with diabetes

This is mainly due to the high prevalence of obesity and related metabolic disorders in the region, driving strong demand for effective treatments

In 2024, a multi-society clinical practice guideline was issued jointly by the American Gastroenterological Association, the American Society for Metabolic and Bariatric Surgery, the American Society of Anesthesiologists (ASA), the International Society of Perioperative Care of Patients with Obesity, and the Society of American Gastrointestinal and Endoscopic Surgeons [112]

Phys Ther

Although the trial is ongoing, specific predictor markers suggest its early termination due to the successful results obtained so far [48]